UK inquiry into the forgotten500k immunocompromised patients

The UK inquiry into the forgotten500k immunocompromised patients has been set up to examine the UK’s response to and impact of the COVID-19 pandemic to this highly vulnerable group in order to learn lessons for the future.

The inquiry will be delivered by the All Party Parliamentary groups for Vulnerable Groups to Pandemics co-chaired by Bob Blackman MP and Lord Mendelsohn (a cross party group of UK parliamentarians who are concerned about the needs of vulnerable groups during this pandemic)

Five modules will be assessed as part of the UK inquiry, including i) availability and access of pharmaceutical products, ii) decision making, iii) research, iv) communication with stakeholders, v) digital and data.

The report will be overseen by patient leads, Prof Martin Eve, Mark Oakley, Nikola Brigden, national pandemic public affairs intern Keeley Bernhardt, national immunocompromised clinical champion Dr Lennard Lee and has the support of the RPP group

Evidence and responses are being sought from hospitals, patient groups, charities, clinicians, academics and private companies.

The findings of the reports will be crucial to consider carefully the experience of the forgotten500k immunocompromised patients and the effect of government responses to this group.

To submit evidence, please click this link. The inquiry will collect until the end of working day on the 17th of January 2023